Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma

Liposomes constitute one of the most popular nanocarriers for improving the delivery and efficacy of agents in cancer patients. The purpose of this study was to design and evaluate immunoliposome co-delivery of bufalin and anti-CD40 to induce synergetic therapeutic efficacy while eliminating systemi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Nanomedicine
Huvudupphovsmän: Li, Ying, Yuan, Jiani, Yang, Qian, Cao, Wei, Zhou, Xuanxuan, Xie, Yanhua, Tu, Honghai, Zhang, Ya, Wang, Siwang
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2014
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260685/
https://ncbi.nlm.nih.gov/pubmed/25506218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S73651
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk